Fioretto, P., Giaccari, A., & Sesti, G. (2015). Efficacy and safety of dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in diabetes mellitus. Cardiovasc Diabetol.
Chicago Style CitationFioretto, Paola, Andrea Giaccari, and Giorgio Sesti. "Efficacy and Safety of Dapagliflozin, a Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor, in Diabetes Mellitus." Cardiovasc Diabetol 2015.
MLA CitationFioretto, Paola, Andrea Giaccari, and Giorgio Sesti. "Efficacy and Safety of Dapagliflozin, a Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor, in Diabetes Mellitus." Cardiovasc Diabetol 2015.
Warning: These citations may not always be 100% accurate.